-EGENS

Background

Established in 1999, EGENS is a national high-tech enterprise integrating bio-material development, diagnostic reagent production, and global trade. Headquartered in BioSpark, the company operates its own research institute and R&D centers in Beijing, Wuxi, and Zhengzhou, focusing on R&D and production of in vitro diagnostic reagents, nanobodies, genetically engineered antigens, monoclonal antibodies, PCR reagents, and testing equipment.

EGENS leads the industry in multiple fields, including home reproductive health testing, drug and substance abuse detection, infectious disease testing, and cancer diagnostics.

Case details

• Total Investment: RMB 600 million

• Site Area: 31,455 m²

• Products: IVD